Browse Contrast media (Chemicals) topic

Subtopics (18)

Articles

1-100 out of 100 article(s)

Title	Author	Type	Date	Words
Germany : Agfa Healthcare to buy European contrast media company.			Nov 27, 2009	77
Covidien Submits Label Change for Optimark[TM] Contrast Agent.			Nov 9, 2009	950
Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in The U.S., Presented At MRA-Club 09: The 21st Annual International Conference on Magnetic Resonance Angiography.		Conference news	Oct 8, 2009	970
A review of iodine toxicity reports.		Brief article	Oct 1, 2009	177
New Study Demonstrates NanoScan's Novel Contrast Agent May Identify Heart Attack in Waiting.			Jun 11, 2009	780
A case of bilateral tuberculosis with a presenting symptom of massive haemoptysis/Masif hemoptizi ile bulgu veren bilateral tuberkuloz olgusu.	Ozgen, Aylin; Celik, Pinar; Gulcu, Aytac; Konyar, Isin; Coskun, Aysin Sakar; Goktan, Cihan; Yorganci	Report	Jun 1, 2009	1818
Cook Medical Launches Industry-First Pressure Injection Peripherally Inserted Catheter with Antibiotic Protection to Prevent Potentially Fatal Infections.			May 11, 2009	757
Lantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights to MS-325 (Formerly Marketed as VASOVIST[R], Gadofosveset Trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals.			Apr 7, 2009	1198
MRI in the era of nephrogenic systemic fibrosis: review, controversies and suggestions for risk reduction.	Kuo, Phillip H.; Abu-Alfa, Ali; Bucala, Richard; Griffith, Jason; Carlson, Kacie; Girardi, Michael;	Clinical report	Apr 1, 2009	5787
Detecting metastatic cancer lesions ... before it is too late!	Goepp, Julius	Report	Mar 1, 2009	6012
United States: Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis.			Jan 3, 2009	404
Imaging of appendicitis.	Gajjar, Himal; Levy, Anthony	Clinical report	Dec 1, 2008	1941
Study shows GE Healthcare's VisipaqueTM Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide.		Clinical report	Nov 21, 2008	1081
Cook Medical Brings Power Injection Capability of Contrast Media to Spectrum(R) Antimicrobial Central Venous Catheter Line.			Oct 28, 2008	475
Hospitals, Healthcare Providers to Save with Premier Agreement for Cardiac Ultrasound Contrast Media.			Oct 23, 2008	214
Luna Innovations Receives Funding for Brain Cancer Diagnostic Agent Using Nanotechnology.			Oct 7, 2008	878
Myocardial blushing during coronary angiography due to high pressure applied by an inexperienced operator/Tecrubesiz bir operatorun koroner anjiyografi sirasinda uyguladigi yuksek basinca bagli miyokardiyal boyanma.	Ozkan, Mustafa; Sag, Cemal; Yokusoglu, Mehmet; Uzun, Mehmet	Case study	Aug 1, 2008	289
Milk found effective, low-cost contrast agent.		Report	Aug 1, 2008	320
Milk gets mixed reviews as a contrast agent.		Report	Aug 1, 2008	433
Late-Breaking Clinical Trial Results Reveal No Statistically Significant Difference between Isovue(R)-370 (Iopamidol Injection), or Visipaque(TM) 320 (Iodixanol) Injection in the Rate of CIN in High-Risk Patients Undergoing Computed Tomography.		Clinical report	Jul 31, 2008	1069
Covidien Launches Contrast Delivery System with RFID.			Jul 28, 2008	583
Published Study Demonstrates Lower Serum Creatinine Levels after Contrast Media Administration with Iodixanol Than with Iopromide.			Jul 16, 2008	692
EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries.			Jul 10, 2008	615
Is MRI as safe as we think?	Wahab, S.; Khan, R.A.; Ullah, E.; Wahab, A.	Report	Jul 1, 2008	2040
United States: Luna nanoWorks' Next-Generation MRI Contrast Agent Breakthrough Published in Journal of Medicinal Chemistry.			Jun 27, 2008	364
CONTRAST Study: To What Extent Do High-Risk Patients Benefit From the Renal Tolerance of Iso-Osmolar X-Ray Contrast Media?			Jun 6, 2008	640
FDA Approves Covidien Contrast Delivery System with RFID.			May 7, 2008	766
Omniscan (gadodiamide) injection for intravenous use.		Brief article	May 6, 2008	74
Chronic kidney disease: CT or MRI?	Morcos, Sameh K.	Clinical report	May 1, 2008	3799
Luna Innovations Successfully Demonstrates MRI Contrast Agent.			Apr 30, 2008	996
Luna Innovations Plans Preclinical Studies and Collaboration with National Cancer Institute.			Apr 9, 2008	894
Cheap drug protects kidneys from contrast agent harm.		Brief article	Apr 1, 2008	168
Iodixanol vs Iopromide Study Abstract Presented at American College of Cardiology 2008.		Clinical report	Apr 1, 2008	497
Review of common and uncommon contrast media reactions.	Hesley, Gina; Hartman, Robert		Apr 1, 2008	2226
Germany: Bayer introduces innovative contrast media management system.			Mar 21, 2008	158
United Kingdom: Bayer introduces innovative contrast media management system.			Mar 20, 2008	377
Management of hypopharyngeal and esophageal perforations in children: three case reports and a review of the literature.	Baum, Eric D.; Elden, Lisa M.; Handler, Steven D.; Tom, Lawrence W.C.	Clinical report	Jan 1, 2008	2048
Assessing renal function before administering contrast media.	Dallessio, Kathleen M.		Dec 1, 2007	1098
Luna Works with the National Institutes of Health Exploring New Diagnostics for Heart Attack Prevention.			Nov 29, 2007	1062
Insight Agents Launches Generic Contrast Media and Attractive Business Model in Europe.			Nov 23, 2007	748
HealthTrust Purchasing Group and Bracco Diagnostics Inc. Sign Three-Year Agreement for X-Ray Contrast Media.			Nov 9, 2007	651
ACRIN TRIAL EVALUATES IMAGING FOR STAGING CERVICAL CANCER.			Nov 1, 2007	438
Revised labels for contrast agents due to deaths.		Brief article	Oct 22, 2007	201
FDA Clears Hand-Held Disposable Injector for Angiographic Imaging.			Oct 10, 2007	384
Ultrasound drugs face black-box warning.			Oct 8, 2007	385
FDA, Bayer issue letter to doctors about MRI agents.		Brief article	Oct 8, 2007	210
Bracco Diagnostics Inc. and HealthTrust Purchasing Group Sign a Three-Year Agreement for Contrast Media.			Oct 5, 2007	836
Frost & Sullivan Lauds the Outstanding Product Quality of Guerbet's Flagship X-ray Contrast Agent.		Company overview	Sep 20, 2007	807
Reactions to new contrast agents rare in children.		Brief article	Aug 1, 2007	205
FDA requests warning for MR contrast agents.		Brief article	Aug 1, 2007	184
Intratracheal ectopic thyroid: case report and review.	Karakullukcu, Baris; Guvenc, M. Gtiven; Cansiz, Harun; Oktem, Fatih; Oz, Buge	Clinical report	Jul 1, 2007	2109
FDA requests boxed warning for MRI contrast agents.			Jun 4, 2007	355
Panel considers contrast safety measures.	Faguy, Katie		Jun 1, 2007	1117
MRI contrast agents tied to rare skin disease in kidney patients.			Mar 26, 2007	465
MR contrast agent implicated in serious skin condition.			Feb 1, 2007	422
Myelography in the pigeon (Columba livia).	Naeini, Aboutorab Tabatabaei; Dadras, Habibollah; Naeini, Bahram Ataei		Mar 1, 2006	1814
MR contrast agents.	Kalva, Sanjeeva P.; Blake, Michael A.; Sahani, Dushyant V.		Jan 1, 2006	3755
Contrast-medium-induced nephrotoxicity.	Thomsen, Henrik S.; Morcos, Sameh K.		Jan 1, 2005	4958
Make thin-wall catheters show up on X-Rays. (Keeping up with Materials).		Brief Article	Feb 1, 2002	63
North American Scientific's Apomate for use in cardiac transplant rejection diagnosis receives orphan drug designation.		Brief Article	Dec 29, 2000	107
Enhancement along the facial nerve on MRI.	Valvassori, Galdino		Oct 1, 2000	245
Acetylcysteine May Protect Against Contrast-Induced Renal Dysfunction.			Oct 1, 2000	1290
ACIST GETS FDA CLEARANCE FOR CONTRAST MANAGEMENT SYSTEM.		Brief Article	Jul 1, 2000	690
Nonenhanced Helical CT Accurate in Suspected Acute Appendicitis.			Mar 1, 2000	1720
Renal Cysts May Artificially Enhance Due to Surrounding Parenchymal Enhancement.			Jan 1, 2000	1360
U.S. Patent Office Issues Final Rejection of Key Nycomed Patent.		Article	Aug 25, 1998	459
REPEAT/Diatide Submits Second New Drug Application to the FDA.		Article	Jun 16, 1998	822
Molecular Biosystems and Mallinckrodt Launch OPTISON in Europe; Product Shipped Within 24 Hours of Approval.			May 27, 1998	456
Molecular Biosystems Reports Initial Sales of OPTISON, Q4 and Fiscal Year-End Financial Results.			May 13, 1998	889
Kaire Holdings Incorporated's Potomac Chemicals Sets April 23, 1998 for Its Seventh Anniversary Meeting of Its Mainland China's 300,000 Consumer Distributors.			Apr 13, 1998	184
OPTISON Recommended for European Approval; New Ultrasound Imaging Agent Will Aid in the Detection of Cardiac Disease.			Jan 29, 1998	677
OPTISON Off to a Solid Start in Ultrasound Imaging Market.			Jan 28, 1998	733
Molecular Biosystems Reports Third Quarter Financial Results.			Jan 21, 1998	1457
Diatide's Acutect Scheduled For FDA Panel Review.			Jan 9, 1998	847
New Ultrasound Imaging Agent, Optison, Cleared by FDA; First of the New Generation Ultrasound Agents.			Jan 5, 1998	718
Diatide's Lung Cancer Imaging Product is Presented at the American College of Chest Physicians Annual Meeting.			Oct 29, 1997	726
Syncor Reports Third Consecutive Quarter of Double Digit Growth in Net Income From Continuing Operations.			Oct 24, 1997	997
Molecular Biosystems Reports Second-Quarter Financial Results.			Oct 23, 1997	777
Palatin Submits IND With The FDA For Kit-Packaged Radioimaging Diagnostic System; IND Filed With FDA.			Oct 15, 1997	381
U.S. Patent Office to Reconsider Validity of Nycomed Contrast Agent Patent.			Sep 25, 1997	511
Alliance Pharmaceutical Corp. Announces Agreement With Schering AG, Germany, For Ultrasound Contrast Agent.			Sep 24, 1997	605
New Diagnostic Imaging Technology Promises To Change How Lung Cancer is Diagnosed and Treated; By Better Staging Progress of Disease, ADAC Laboratories' MCD May Reduce Unnecessary Lung Cancer Surgery.			Aug 24, 1997	834
Molecular Biosystems Reports First Quarter Financial Results.			Aug 7, 1997	905
E-Z-EM Inc. introduces contrast agent for new "see-through" small bowel radiographic study; Entero Vu(TM) provides detailed images not possible with conventional small bowel x-ray examination.			Sep 5, 1996	419
Molecular Biosystems Announces Favorable Phase 3 Clinical Trial Results of its Ultrasound Contrast Agent, FS069.			Jul 17, 1996	1160
Landmark agreement in radiographic contrast media market announced by Bracco Diagnostics and AmeriNet.			Jun 3, 1996	427
Molecular Biosystems completes public offering of 3.6 MM shares of common stock.			May 24, 1996	164
E-Z-EM Inc. announces third quarter fiscal 1996 results; Earnings from continuing operations increased 87% from first nine months of fiscal 1995.			Apr 16, 1996	818
Alliance Pharmaceutical Corp. announces public offering.			Apr 2, 1996	181
Smart molecules may enhance images.	Lipkin, Richard		Feb 17, 1996	498
E-Z-EM, introduces new contrast medium for abdominal/pelvic CT studies; Product offers benefits and safety not available with iodinated contrast agents.			Feb 15, 1996	325
Interactive Medical Technologies Ltd. finalizes agreement with E-Z-EM Inc.			Feb 7, 1996	345
E-Z-EM declares stock dividend.			Jan 26, 1996	200
Advanced Magnetics reports first fiscal quarter results.			Jan 17, 1996	462
NJHA/Bracco Diagnostics sign long-range contract.			Dec 5, 1995	240
E-Z-EM Inc. completes divestiture of subsidiary to U.S. Surgical.			Nov 27, 1995	264
Alliance Pharmaceutical Corp. announces first-quarter financial results.			Nov 13, 1995	438
Immunomedics and FDA planning Medical Imaging Drugs Advisory Committee hearing for CEA-Scan.			Nov 1, 1995	358
Molecular Biosystems appoints Bobba Venkatadri president and chief operating officer.			Oct 18, 1995	369
FDA Advisory Panel Defers Decision on Immunomedics' CEA-Scan for Colorectal Cancer Imaging.			Oct 18, 1995	333